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12 french 18 french Mark A. Hlatky, Pamela S. Douglas, Nakela L. Cook, Barbara Wells, Emelia J. Benjamin, Kay Dickersin,
David C. Goff, Alan T. Hirsch, Elaine M. Hylek, Eric Peterson, Véronique L. Roger, Joseph V. Selby,
James E. Udelson, Michael S. Lauer
Comparative effectiveness research (CER) aims to provide decision-makers the evidence
needed to evaluate the benefits and harms of alternative clinical management strategies.
CER has become a national priority, with considerable new research funding allocated and
cardiovascular disease has been identified as a priority area for CER. This workshop report
provides an overview of CER methods and details recommendations made to the National
Heart, Lung, and Blood Institute for a new framework for evidence development to foster
cardiovascular CER.CLINICAL RESEARCH INTERVENTIONAL CARDIOLOGY581First Clinical Experience With a Repositionable Transcatheter Aortic ValveAlexander B. Willson, Josep Rodès-Cabau, David A. Wood, Jonathon Leipsic, Anson Cheung,
Stefan Toggweiler, Ronald K. Binder, Melanie Freeman, Robert DeLarochellière, Robert Moss,
Luis Nombela-Franco, Eric Dumount, Karolina Szummer, Gregory P. Fontana, Raj Makkar, John G. Webb
Willson and colleagues describe their initial experience with a novel self-expanding and
repositionable transcatheter heart valve. Suboptimal prosthesis positioning may contribute to
paravalvular regurgitation, atrioventricular conduction block, and mitral or coronary
compromise. The Portico valve (St. Jude Medical, Minneapolis, Minnesota) allows the
inferior portion of the valve containing the leaflets, to be deployed and assessed; if satisfactory,
the upper portion is expanded, and if unsatisfactory, the valve can be retrieved into the sheath
and repositioned. Device implantation was successful in all 10 patients with prosthesis
recapture and repositioning performed in 4 patients. At 30-day follow up echocardiographic
mean transaortic gradient was reduced with only 1 case of moderate paravalvular
regurgitation.(continued on page A-27)
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587mproved Clinical Outcomes With
SES for Treatment of Infrapopliteal ArteriesAljoscha Rastan, Klaus Brechtel, Hans Krankenberg, Rainer Zahorsky, Gunnar Tepe, Elias Noory,
Uwe Schwarzwälder, Roland Macharzina, Thomas Schwarz, Karlheinz Bürgelin, Sebastian Sixt,
Thilo Tübler, Franz-Josef Neumann, Thomas Zeller
Rastan and colleagues investigated the long-term clinical impact of sirolimus-eluting stents
(SES) compared to bare-metal stents (BMS) for the treatment of focal infrapopliteal lesions.
Subjects with focal infrapopliteal de-novo lesions were randomized to either a polymer-free
SES or placebo coated BMS. The main study endpoint, which was the event-free survival
rate defined as freedom from target limb amputation, target vessel revascularization,
myocardial infarction and death, was significantly lower with SES (45% vs. 66%). Ampu-
tation rates were 2.6% and 12.2, and target vessel revascularization rates were 9.2% and 20%,
all favoring SES. These results show convincing superiority of SES to BMS for the treatment
of focal infrapopliteal lesions.CARDIAC RESYNCHRONIZATION592EF Improvement After CRT Only Seen in Patients With LBBBMatthias Dupont, John Rickard, Bryan Baranowski, Niraj Varma, Thomas Dresing, Alaa Gabi,
Michael Finucan, Wilfried Mullens, Bruce L. Wilkoff, W. H. Wilson Tang
Dupont and colleagues examined the relative impact of QRS morphology and
duration in predicting which patients will have an echocardiographic response to
cardiac resynchronization therapy (CRT). Subjects who received a CRT were stratified
into 4 groups based on QRS duration (QRSd) above or below 150 ms and the presence
of absence of a left bundle branch block (LBBB) morphology on their pre-implantation
electrocardiogram. The change in ejection fraction was highest in patients with LBBB
and a QRSd 150 ms (12%) with minimal changes in those with non-LBBB regardless
f QRSd. LBBB QRS morphology is a more important baseline electrocardiographic
eterminant of CRT response than QRS duration.HYPERTENSION
599rends in Prevalence, Awareness, Management,
and Control of Hypertension Among U.S. AdultsFangjian Guo, Di He, Wei Zhang, R. Grace Walton
Guo and colleagues sought to quantify the trends in hypertension prevalence, awareness,
management, and control in U.S. adults from 1999 to 2010. Data was collected from the
annual National Health and Nutrition Examination Survey (NHANES) surveys. In 2009 to
2010, the prevalence of hypertension was 31% in men, and 29% in women with hypertension
awareness rates of 70% and 81%, respectively. Over the 12-year period, the prevalence of
hypertension remained stable but hypertension awareness, management, and control were all
improved. Despite these improvements, there is still significant room for improvement.(continued on page A-28)
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Mary Anne Elma, Mary Norine Walsh, Harlan M. Krumholz
Bradley and colleagues sought to determine the range and prevalence of practices being
implemented to reduce 30-day readmissions of patients with heart failure or acute myocardial
infarction (AMI). Representatives from the almost 600 hospitals enrolled in the Hospital to
Home quality improvement initiative completed a web-based survey. Nearly 90% of hospitals
had a written objective of reducing preventable readmissions. On average, hospitals used 4.8
of 10 key practices, but fewer than 3% of hospitals utilized all 10 practices. These results
show wide variability in the use of strategies to reduce readmissions.Editorial Comment: Javed Butler, Andreas Kalogeropoulos, p. 615PRE-CLINICAL RESEARCH PRE-CLINICAL RESEARCH618Anti-VEGF Therapy Leads to Hypertension Through Multiple PathwaysJ. Todd Belcik, Yue Qi, Beat A. Kaufmann, Aris Xie, Sherry Bullens, Terry K. Morgan, Susan P. Bagby,
Ganesh Kolumam, Joe Kowalski, Jon A. Oyer, Stuart Bunting, Jonathan R. Lindner
Belcik and colleagues sought to evaluate the factors that cause hypertension and secondary
ventricular remodeling in cancer patients treated with anti-vascular endothelial growth factor
(VEGF) therapy. Mice were treated for 5 weeks with a VEGF-A monoclonal antibody,
antibody plus ramipril, or sham treatment. Ambulatory blood pressure increased gradually
over the first 3 weeks of anti-VEGF therapy. Compared to controls, anti-VEGF treated mice
had a marked increase in arterial elastance, indicating increased afterload, and elevated plasma
angiotensin II. Anti-VEGF therapy did not alter microvascular blood flow or blood volume,
but did produce cortical mesangial glomerulosclerosis. Ramipril therapy almost entirely
prevented the adverse hemodynamic effects in anti-VEGF treated mice. Inhibition of VEGF
leads to an afterload mismatch state, a process that is likely complex and multifactorial.Editorial Comment: Michael Simons, Anne Eichmann, p. 626EXPEDITED PUBLICATIONS EXPEDITED PUBLICATIONS628Ablation of Atrial Fibrillation SourcesSanjiv M. Narayan, David E. Krummen, Kalyanam Shivkumar, Paul Clopton, Wouter-Jan Rappel,
John M. Miller
Narayan and colleagues hypothesized that human atrial fibrillation (AF) may be sustained by
localized sources (electrical rotors and focal impulses), whose elimination (Focal Impulse and
Rotor Modulation, FIRM) would improve outcomes for AF ablation procedures. 92
individuals with paroxysmal or persistent AF were treated with either ablation at sources
(FIRM-Guided) followed by conventional ablation or conventional ablation alone. Localized
rotors or focal impulses were detected in 97% of cases with sustained AF. AF termination or
consistent slowing was achieved in 86% of FIRM-guided versus 20% of FIRM-Blinded cases.
Freedom from AF during follow-up was higher in FIRM-Guided cases (82% versus 45%).
Localized electrical rotors and focal impulse sources are prevalent sustaining-mechanisms for
human AF and targeting these locations may improve AF ablation success rates.Editorial Comment: Karl-Heinz Kuck, Erik Wissner, p. 637
